Recital 8, Commission Regulation (EU) No 200/2012 of 8 March 2012 concerning a Union target for the…

In forcesince 8 Mar 2012

Monophasic strains of Salmonella typhimurium have developed to be among the most frequently detected Salmonella serotypes in several species of animals and in clinical isolates from humans in recent years. EFSA's 2010 Scientific Opinion on monitoring and assessment of the public health risk of "Salmonella typhimurium-like strains" adopted on 22 September 2010 [EFSA Journal 2010; 8(10):1826.] also stated that monophasic Salmonella typhimurium strains with the antigenic formula 1,4,[5],12:i:-, which includes strains with and without the O5 antigen, have to be considered to be variants of Salmonella typhimurium and to pose a public health risk comparable to that of other Salmonella typhimurium strains. Salmonella typhimurium strains with the antigenic formula 1,4,[5],12:i:- should therefore be included in the target.